Gkotzamanidou M, Dimopoulos MA, Kastritis E, Christoulas D, Moulopoulos LA, Terpos E. Sclerostin: A possible target for the management of cancer-induced bone disease. Expert Opinion on Therapeutic Targets [Internet]. 2012;16(8):761 - 769.